Search Results 2241-2250 of 14761 for anti-TNF drugs

  1. Ponatinib (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  2. Fat Emulsion (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Clinolipid; Liposyn; Omegaven. Descriptions.

  3. Calcipotriene (Topical Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  4. Docetaxel (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... [anti-HBc] and/or antibodies to hepatitis B ...

  6. Testosterone (Topical Application Route) Proper Use - Mayo Clinic

    This medicine comes with a Medication Guide and patient instructions. Read and follow these instructions carefully. Ask your doctor if you have any questions.

  7. Atropine (Intramuscular Route) Description and Brand Names - Mayo Clinic

    Atropine injection is used to treat poisoning caused by organophosphorus nerve agents, including organophosphorus or carbamate insecticides.

  8. A Study of the Safety and Effectiveness of Using Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-leukemic agents (for example, anthracyclines ...

  9. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Known diagnosis of triple positive (i.e., positive for lupus ...

  10. Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients - Mayo Clinic

    Participation eligibility · Patients with acute promyelocytic leukemia · Treatment with chemotherapy or biologic therapy within 3 weeks, except for hydroxyurea, ...